Dr. Jeremiah D. Momper is a Professor of Clinical Pharmacy at the Skaggs School of Pharmacy and
Pharmaceutical Sciences, University of California San Diego. He obtained his Pharm.D. and Ph.D. in Pharmaceutical Sciences from the University of Pittsburgh in 2006 and 2011, respectively. After completing his Ph.D., he worked as a Commissioner’s Fellow at the Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration from 2011 to 2013. He joined the University of California San Diego as an Assistant Professor in 2013 and became a Professor
in 2023. He also served as a Consultant of Pharmacokinetics at Epocrates, Inc. from 2012 to 2022. Dr. Momper’s research focuses on the application of quantitative pharmacology approaches to optimize the development and clinical use of drugs. His current research directions include the evaluation of potential therapies for HIV infection in infants and pregnant women and the use of model-based methods to support scientific decision-making in drug development. He also directs the Translational Pharmacology and Bioanalysis Laboratory concentrated on novel mass spectrometry-based analytical methods, in vitro ADME assays, and pre-clinical and clinical pharmacokinetic studies.
Dr. Jeremiah D. Momper is a Professor of Clinical Pharmacy at the Skaggs School of Pharmacy and
Pharmaceutical Sciences, University of California San Diego. He obtained his Pharm.D. and Ph.D. in Pharmaceutical Sciences from the University of Pittsburgh in 2006 and 2011, respectively. After completing his Ph.D., he worked as a Commissioner’s Fellow at the Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration from 2011 to 2013. He joined the University of California San Diego as an Assistant Professor in 2013 and became a Professor
in 2023. He also served as a Consultant of Pharmacokinetics at Epocrates, Inc. from 2012 to 2022. Dr. Momper’s research focuses on the application of quantitative pharmacology approaches to optimize the development and clinical use of drugs. His current research directions include the evaluation of potential therapies for HIV infection in infants and pregnant women and the use of model-based methods to support scientific decision-making in drug development. He also directs the Translational Pharmacology and Bioanalysis Laboratory concentrated on novel mass spectrometry-based analytical methods, in vitro ADME assays, and pre-clinical and clinical pharmacokinetic studies.